Search
for

    Sort by

    Research 61–90 of 1000+

    1. Metformin and Malignant Tumors: Not Over the Hill Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · 2021 · 14 citations
    2. Slow progress in prostate cancer BJUI · 2007
    3. TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine Clinical Cancer Research · 2006
    4. Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link? 2018 · 12 citations
    5. Paradigm Shift in the Concept of Hormonal Milieu of Prostate Cancer InTech eBooks · 2011
    6. Five-alpha-reductase Inhibitors for prostate cancer prevention. The Cochrane library · 2008 · 37 citations
    7. The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs) Proteomes · 2023 · 4 citations
    8. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021 · 8 citations
    9. Referee report. For: Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment [version 3; peer review: 2 approved] Faculty of 1000 Research Ltd · 2021
    10. 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives International Journal of Biological Macromolecules · 2011 · 26 citations
    11. Design, synthesis and structure-activity relationships studies on steroidal aromatase and 5α-reductase inhibitors as anti-tumors Estudo Geral (Universidade de Coimbra) · 2013
    12. ダブルストロボレンジファインダの開発(特別講演)(画像センシングおよび一般) 映像情報メディア学会技術報告 · 2002
    13. Finasteride en el año 2006 Revista Argentina de Urología · 2006
    14. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II Mayo Clinic Proceedings · 2006 · 2 citations
    15. Synthesis and structure–activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands Bioorganic & Medicinal Chemistry Letters · 2001 · 18 citations
    16. Synthesis and structure–activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands Bioorganic & Medicinal Chemistry Letters · 2004 · 6 citations
    17. Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice PLOS ONE · 2013 · 9 citations
    18. 5ARIs and PSA: Evidences Urologia Journal · 2014 · 3 citations
    19. 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond European Urology Supplements · 2006 · 2 citations
    20. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I Mayo Clinic Proceedings · 2006 · 2 citations
    21. Traditional uses, phytochemistry, pharmacology, toxicity and clinical application of traditional Chinese medicine Cynoglossum amabile: a review Frontiers in pharmacology · 2024
    22. Steroidogenesis in steroid related cancers University of Birmingham Institutional Research Archive (University of Birmingham) · 2016
    23. Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · 2007 · 20 citations
    24. Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases Current Medicinal Chemistry · 2016 · 11 citations
    25. Tracing the cellular origin of cancer Nature Cell Biology · 2013 · 232 citations
    26. WNT10B (wingless-type MMTV integration site family) Atlas of genetics and cytogenetics in oncology and haematology · 2018
    27. Focus sulla finasteride: efficacia, meccanismi e raccomandazioni per l'uso clinico Gazzetta Medica Italiana Archivio per le Scienze Mediche · 2026
    28. Every TURP Is not Just BPH American Journal of Clinical Pathology · 2022
    29. Heavy metals in biological samples of cancer patients: a systematic literature review BioMetals · 2024
    30. Combined C3b and Factor B Autoantibodies and MPGN Type II New England Journal of Medicine · 2011 · 97 citations